Prominent Psychiatric Symptoms and Glucose Hypometabolism in a Family with a SNCA Duplication
Authors
Affiliations
Duan R, Liu G, Han Y, Li P, Zhang B, Liu Y Mov Disord Clin Pract. 2023; 10(10):1536-1541.
PMID: 37868923 PMC: 10585967. DOI: 10.1002/mdc3.13852.
Therapeutics in the Pipeline Targeting -Synuclein for Parkinson's Disease.
Jasutkar H, Oh S, Mouradian M Pharmacol Rev. 2022; 74(1):207-237.
PMID: 35017177 PMC: 11034868. DOI: 10.1124/pharmrev.120.000133.
Dementia with Lewy bodies: an update and outlook.
Outeiro T, Koss D, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D Mol Neurodegener. 2019; 14(1):5.
PMID: 30665447 PMC: 6341685. DOI: 10.1186/s13024-019-0306-8.
Jewett M, Dickson E, Brolin K, Negrini M, Jimenez-Ferrer I, Swanberg M Front Neurol. 2018; 9:222.
PMID: 29681884 PMC: 5897443. DOI: 10.3389/fneur.2018.00222.
α-Synuclein and Parkinsonism: Updates and Future Perspectives.
Rosborough K, Patel N, Kalia L Curr Neurol Neurosci Rep. 2017; 17(4):31.
PMID: 28324300 DOI: 10.1007/s11910-017-0737-y.